Google
Trusted Resources: News & Events
Latest announcements and gatherings
University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain research
The University of Illinois at Chicago has been awarded a $4.6 million grant from the National Heart, Lung, and Blood Institute to study the molecular neurobiology of chronic pain in patients with sickle cell disease and to develop potential new drug treatments.
While there have been many advances in managing the disease and acute pain crises, researchers still do not know much about how and why patients experience chronic pain.
The new funding will provide an opportunity for investigators to refine their tools and develop new therapeutic leads for treating chronic pain in sickle cell disease. They hope to identify various molecular mechanisms and explore ways to target one or more of these mechanisms for controlling pain in sickle cell disease.
+myBinderRelated Content
-
Barbara Speller Brown, DNP, MSNBarbara Speller-Brown, DNP, MSN, PNP-BC,...
-
Yutaka Niihara, MD, MPHDr. Niihara has been involved in patient...
-
Loma Linda University Medical CenterA new movement for patients who suffer f...
-
Provider Perspectives of Necessary Factors in Sickle Cell Disease Health Care Transition: Results from an Online Sur...Introduction: Survivorship of children w...
-
Implementation of a social worker screening process to explore unmet psychological and social needs for adults with ...The most common symptom for persons with...
-
A Health Note From Dr. Biree Andemariam, SCDAA Chief Medical OfficerWhat You Need to Know About the Coronavi...
-
Four Solutions for Sickle Cell Disease SupportWhen Precious Lee was a year old, she be...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.